SYNA Q1 2026 Earnings EPS Surpasses Estimates as Operating Disciplines Shine CURI Q1 2026 Earnings EPS Miss Amid Subscriber Challenges EOG Q1 2026 Earnings Strong EPS Beat Drives Upbeat Investor Sentiment Actuate Therapeutics Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss Climb Bio Inc Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Sentiment MESO Q1 2026 Earnings EPS Miss Amid Ongoing Pipeline Progress